Clinical trial of newest technology to treat thoracic aortic aneurysms

A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms.
Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.

read more:


Popular posts from this blog

Early Intervention in Unstable CAD

Amsterdam to Host EU Drug Agency

Inflammatory Bowel Disease an Independent Risk Factor for MI